Pharma Mar, S.A. (PHMMF)

Pharma Mar Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.29	63.24	60.02	149.81	113.35	96.21
Short-Term Investments	80.55	91.29	102.54	32.61	88.53	99.31
Cash & Short-Term Investments	140.85	154.53	162.56	182.42	201.88	195.52
Cash Growth	-11.82%	-4.94%	-10.89%	-9.64%	3.26%	835.71%
Accounts Receivable	36.77	34.27	27.2	29.32	50.91	24.05
Other Receivables	-	0.41	0.35	-	-	-
Receivables	36.77	34.68	27.55	29.32	50.91	24.05
Inventory	50.53	50.89	39.29	27.75	10.54	11.93
Prepaid Expenses	1.35	1.74	2.92	5.98	3.91	1
Other Current Assets	6.52	8.41	20.28	29.71	28	13.15
Total Current Assets	236.01	250.25	252.6	275.18	295.23	245.65
Property, Plant & Equipment	58.26	57.75	34.54	33.23	26.9	24.75
Long-Term Investments	1.38	2.46	6.06	49.4	10.72	20.99
Other Intangible Assets	1.02	1	1.23	1.19	1.13	0.99
Long-Term Deferred Tax Assets	35.99	36.01	31.47	30.53	27.75	33.42
Long-Term Deferred Charges	-	-	0.7	1.4	2.11	2.81
Other Long-Term Assets	0.85	2.18	13.91	2.33	4.55	1.67
Total Assets	333.5	349.64	340.52	393.26	368.39	330.26
Accounts Payable	42	38.81	29.17	27.49	26.93	21.04
Accrued Expenses	5.21	13.57	12.39	10.44	9.5	8.79
Short-Term Debt	5.01	4.72	6.46	4.48	3.84	4.77
Current Portion of Long-Term Debt	4.91	3.25	6.37	8.64	8.37	10.54
Current Portion of Leases	1.79	1.88	1.98	1.61	1.82	1.47
Current Unearned Revenue	3.97	5.38	25.93	26.11	30.89	44.71
Other Current Liabilities	16.6	15.08	13.59	18.54	4.99	3.61
Total Current Liabilities	79.49	82.69	95.89	97.32	86.35	94.92
Long-Term Debt	38.59	39.87	27.04	25.88	33.39	37.73
Long-Term Leases	1.64	1.36	1.83	2.01	1.92	2.15
Long-Term Unearned Revenue	16.1	17.17	22.14	44.9	68.63	92.56
Other Long-Term Liabilities	0.2	0.19	0.19	0.19	0.19	0.18
Total Liabilities	136.02	141.29	147.08	170.3	190.47	227.54
Common Stock	10.93	10.93	11.01	11.01	11.01	11.01
Additional Paid-In Capital	59.86	59.86	71.28	71.28	71.28	71.28
Retained Earnings	164.85	168.38	142.22	156.51	121.29	41.87
Treasury Stock	-38.18	-30.83	-31.09	-15.87	-25.68	-21.45
Comprehensive Income & Other	0.02	0.02	0.02	0.02	0.02	0.01
Total Common Equity	197.47	208.36	193.44	222.96	177.92	102.72
Shareholders' Equity	197.47	208.36	193.44	222.96	177.92	102.72
Total Liabilities & Equity	333.5	349.64	340.52	393.26	368.39	330.26
Total Debt	51.94	51.08	43.67	42.63	49.33	56.67
Net Cash (Debt)	88.91	103.45	118.89	139.79	152.55	138.85
Net Cash Growth	-25.58%	-12.99%	-14.95%	-8.36%	9.86%	-
Net Cash Per Share	-	5.89	6.64	7.74	8.44	7.58
Filing Date Shares Outstanding	-	17.57	17.64	18.11	18.01	18.11
Total Common Shares Outstanding	-	17.57	17.64	18.11	18.01	18.11
Working Capital	156.52	167.55	156.71	177.86	208.89	150.73
Book Value Per Share	-	11.86	10.97	12.31	9.88	5.67
Tangible Book Value	196.46	207.36	192.2	221.77	176.79	101.74
Tangible Book Value Per Share	-	11.80	10.90	12.25	9.82	5.62
Land	-	36.04	29.04	29.04	22.59	21.99
Machinery	-	60.68	43.28	27.87	24.32	21.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.